New guidelines from the US Food and Drug Administration (FDA) concerning the development of cancer treatments could have a big impact on the sector, says Genmab’s CEO Jan van de Winkel.
At the end of January, the FDA launched a new project, Optimus, which will require companies developing cancer drugs to do more work to find the optimal dose, so that the best effect can be achieved with the lowest possible dosage.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Rumored GN purchase unlikely but not impossible, say analysts
A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.
EMA begins analyzing Bavarian Nordic's vaccine against monkeypox
Prior to deciding on a shared European vaccine supply purchase, the European Medicines Agency has begun analyzing the Danish firm’s smallpox vaccine against monkeypox.
Bavarian Nordic eyes European monkeypox approval for smallpox vaccine
Bavarian Nordic’s smallpox vaccine, Jynneos, hasn’t yet been approved for monkeypox in Europe, a fact that hasn’t stopped countries there from lining up to secure vaccine supplies in light of the recent outbreak.
New CFO wants to shake things up at WSA
A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.
Chinese patent expiration dates draw closer for Novo Nordisk
In coming years, Novo Nordisk will take blows in the shape of several patents terminating on the second-biggest market for the firm, a Danish media reports.
Senior QA Specialist 
Project Manager & Scrum Master 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
SAP System Specialist (Product Supply) – Business Application Services 
Clinical Trial Manager for development of in vitro diagnostics 
Production Director 
Analytical Coordinator for Analytical Development 
Nordic Medical Affairs Manager 
Senior Manager, Clinical Trial Budget 
Clinical Trial Manager 
(Senior) Drug Substance Specialist 
Industrial Designer- Design Engineer 
Senior Chemical Safety Advisor 
Senior Project Manager (GMP - Life Science) 
Client Talent Acquisition Specialist 
Director for innovative pre-clinical testing unit 
CMO Operations Specialist - screening & selection of CMO/CDMO’s